Senseonics Holdings (SENS) Cash from Financing Activities (2014 - 2026)
Senseonics Holdings (SENS) posted quarterly Cash from Financing Activities of $3.4 million for Q1 2026, down 44.32% year-over-year from $6.1 million in Q1 2025, and up 210.29% quarter-over-quarter from $1.1 million in Q4 2025.
Senseonics Holdings (SENS) Cash from Financing Activities (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Cash from Financing Activities for 13 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 44.32% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $75.5 million (up 229.37% YoY), while the FY2025 annual figure was $78.2 million, up 191.42% from the prior year.
- Cash from Financing Activities advanced to $3.4 million in Q1 2026 per SENS's latest filing, from $1.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $71.1 million in Q2 2025 and bottomed at -$1.8 million in Q2 2022.
- Historically, Cash from Financing Activities has averaged $10.0 million across 5 years, with a median of $5.5 million in 2023.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities sank 118.42% — and 2025, when it soared 7084.77%.
- Senseonics Holdings' Cash from Financing Activities stood at $10.3 million in 2022, then tumbled by 111.39% to -$1.2 million in 2023, then soared by 1294.48% to $14.1 million in 2024, then sank by 92.2% to $1.1 million in 2025, then jumped by 210.29% to $3.4 million in 2026.
- Business Quant data shows SENS's Cash from Financing Activities at $3.4 million in Q1 2026, $1.1 million in Q4 2025, and -$134000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Senseonics Holdings | 560.79 Mn | 320.18 Mn | 8.56 Mn | 108.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 108.66 Mn |
| Jun 30, 2026 | 108.66 Mn |
| Mar 31, 2026 | 3.41 Mn |
| Mar 31, 2026 | 3.41 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | -134,000.00 |
| Sep 30, 2025 | -134,000.00 |
| Jun 30, 2025 | 71.11 Mn |
| Jun 30, 2025 | 71.11 Mn |
| Mar 31, 2025 | 6.12 Mn |
| Mar 31, 2025 | 6.12 Mn |
| Dec 31, 2024 | 14.07 Mn |
| Dec 31, 2024 | 14.07 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Mar 31, 2024 | 10.03 Mn |